The European Commission on Monday said it would provide €400 million in guarantees to an initiative led by the World Health Organisation (WHO), to buy and deliver vaccines to low and middle-income countries.
The initiative, namely COVAX, is also co-led by Gavi, the Vaccine Alliance, and the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, and aims at accelerating the development and manufacturing of COVID-19 vaccines and at guaranteeing fair and equitable access for every country in the world.
“Today, the Commission is announcing a €400 million contribution to COVAX for working together in purchasing future vaccines to the benefit of low and middle income countries. I’m confident this will bring us closer to our goal: beating this virus, together,” said the chief of EU’s Executive arm, Ursula von der Leyen.
She added that almost €16 billion have been pledged since May 4, under the Coronavirus Global Response.
The announcement was also made on Twitter, where von der Leyen posted that the Commission’s move to provide 400 million in guarantees to COVAX, is “a true moment of global solidarity.”
A true moment of global solidarity: @EU_Commission will provide €400 mil. in guarantees to #COVAX to buy & deliver vaccines to low & middle-income countries. Together we make all efforts to speed up development & delivery of coronavirus vaccines to Europeans & rest of the world. pic.twitter.com/BnX3Ph8jfS
— Ursula von der Leyen (@vonderleyen) August 31, 2020
Last week, the EU Executive deposited €336 million to drug maker AstraZeneca to secure at least 300 million doses of its potential COVID-19 vaccine, while it is also in advanced talks with Johnson & Johnson, Moderna, Sanofi and CureVac.